Patent US4680391A successfully refreshed from Google Patents.
US4680391A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Substituted azetidinones as anti-inflammatory and antidegenerative agents
Assignee: Merck and Co Inc
•
Filing: 1985-04-10
•
Granted: 1987-07-14
•
Expires: 2005-04-10
Abstract
Abstract New substituted azetidinones are found to be potent elastase inhibitors and thereby useful anti-inflammatory/antidegenerative agents.
Inventors
- 👤 Raymond A. Firestone
- 👤 Peter L. Barker
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 18:18
CPC Classifications
C; C07; C07D; C07D205/00; C07D205/02; C07D205/06; C07D205/08; C07D205/09; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61P; A61P29/00; A61P3/00; A61P43/00; C07D205/085
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
310 words
A compound of formula ##STR10## wherein: R is hydrogen or C 1-3 alkyl: R 1 is (1) hydrogen; (2) C 1-6 alkyl; (3) C 1-6 alkoxy; (4) C 1-6 alkenyl; or (5) phenyl or phenyl substituted with one or more radicals selected from the group consisting of loweralkyl, hydroxy, alkoxy, halo, nitro, loweralkylthio, arylthio, mercapto, amino, cyano, carboxy, aminosulfonyl, aminosulfenyl, aminosulfinyl, carbamoyl, carbamoyloxy, loweralkyl or aryl sulfonyl, loweralkyl or aryl sulfinyl, SO 3 R 5 , azido, or carboxamido; R 2 is hydrogen; R 3 is (1) SR 5 wherein R 5 represents C 1-6 alkyl, phenyl or substituted phenyl as previously defined; (2) SOR 5 ; (3) C 1-6 alkanoyloxy; (4) COOB or CONBB 1 wherein B and B 1 independently represent (a) H; (b) straight or branched alkyl having from 1 to 20 carbon atoms; (c) aryl having from 6 to 10 carbon atoms; (d) cycloalkyl having from 3 to 8 carbon atoms; (e) straight or branched alkenyl having from 2 to 20 carbon atoms; (f) straight or branched alkynyl having from 2 to 20 carbon atoms; (g) aralkyl, alkaryl, aralkenyl, aralkenyl, alkenylaryl or alkenylaryl wherein alkyl, aryl, alkenyl and alkynyl are as previously defined; the above groups (a)-(g) can be unsubstituted or can be substituted by one or more selected radicals from the group consisting of loweralkyl, hydroxy, alkoxy, halo, nitro, loweralkylthio, arylthio, mercapto, cyano, carboxy, aminosulfonyl, aminosulfenyl, aminosulfinyl, carbamoyl, carbamyloxy, loweralkyl or aryl sulfonyl, loweralkyl or aryl sulfinyl, SO 3 R 5 , azido, amino, or carboxamido; (5) phenyl or substituted phenyl as previously defined; and A is (1) SO 2 R 5 ; or (2) SO 3 - M + wherein M + represents (a) an alkali anion selected from a group consisting of Na + and K + ; or (b) a quaternary ammonium group of formula N + (R 5 ) 4 .
Claim 2
Dependent Claim
310 words
A compound of formula ##STR10## wherein: R is hydrogen or C 1-3 alkyl: R 1 is (1) hydrogen; (2) C 1-6 alkyl; (3) C 1-6 alkoxy; (4) C 1-6 alkenyl; or (5) phenyl or phenyl substituted with one or more radicals selected from the group consisting of loweralkyl, hydroxy, alkoxy, halo, nitro, loweralkylthio, arylthio, mercapto, amino, cyano, carboxy, aminosulfonyl, aminosulfenyl, aminosulfinyl, carbamoyl, carbamoyloxy, loweralkyl or aryl sulfonyl, loweralkyl or aryl sulfinyl, SO 3 R 5 , azido, or carboxamido; R 2 is hydrogen; R 3 is (1) SR 5 wherein R 5 represents C 1-6 alkyl, phenyl or substituted phenyl as previously defined; (2) SOR 5 ; (3) C 1-6 alkanoyloxy; (4) COOB or CONBB 1 wherein B and B 1 independently represent (a) H; (b) straight or branched alkyl having from 1 to 20 carbon atoms; (c) aryl having from 6 to 10 carbon atoms; (d) cycloalkyl having from 3 to 8 carbon atoms; (e) straight or branched alkenyl having from 2 to 20 carbon atoms; (f) straight or branched alkynyl having from 2 to 20 carbon atoms; (g) aralkyl, alkaryl, aralkenyl, aralkenyl, alkenylaryl or alkenylaryl wherein alkyl, aryl, alkenyl and alkynyl are as previously defined; the above groups (a)-(g) can be unsubstituted or can be substituted by one or more selected radicals from the group consisting of loweralkyl, hydroxy, alkoxy, halo, nitro, loweralkylthio, arylthio, mercapto, cyano, carboxy, aminosulfonyl, aminosulfenyl, aminosulfinyl, carbamoyl, carbamyloxy, loweralkyl or aryl sulfonyl, loweralkyl or aryl sulfinyl, SO 3 R 5 , azido, amino, or carboxamido; (5) phenyl or substituted phenyl as previously defined; and A is (1) SO 2 R 5 ; or (2) SO 3 - M + wherein M + represents (a) an alkali anion selected from a group consisting of Na + and K + ; or (b) a quaternary ammonium group of formula N + (R 5 ) 4 .
Claim 3
Dependent Claim
10 words
The group of claim 1 wherein the compound is: trans-3-phenyl-4-ethoxycarbonyl-1-p-nitrophenylsulfonylazetidine-2-one.
Claim 4
Dependent Claim
10 words
The compound of claim 1 wherein the compound is: cis-3-phenyl-4-ethoxycarbonyl-1-p-nitrophenylsulfonylazetidine-2-one.
Claim 5
Dependent Claim
10 words
The compound of claim 1 wherein the compound is: cis-3-(1-propenyl-4-ethoxycarbonyl-1-p-nitrophenylsulfonylazetidin-2-one.
Claim 6
Dependent Claim
10 words
The compound of claim 1 wherein the compound is: cis-4-ethoxycarbonyl-3-n-propyl-1-p-nitro-phenylsulfonylazetidin-2-one.
Claim 7
Dependent Claim
10 words
The compound of claim 1 wherein the compound is: Trans-4-ethoxycarbonyl-3-ethyl-1-p-methylphenylsulfonyl-azetidin-2-one.
Claim 8
Dependent Claim
10 words
The compound of claim 1 wherein the compound is: trans-4-ethoxycarbonyl-3-ethyl-1-p-methylphenylsulfonylazetidin-2-one.
Claim 9
Dependent Claim
10 words
The compound of claim 1 wherein the compound is: 4-ethoxycarbonyl-3-ethyl-1-p-nitrophenylsulfonylazetidin-2-one.
Claim 10
Dependent Claim
10 words
The compound of claim 1 wherein the compound is: cis-4-ethoxycarbonyl-1-p-nitrophenylsulfonyl-3-vinylazetidin-2-one.
Claim 11
Dependent Claim
10 words
The compound of claim 1 wherein the compound is: 4-benzyloxycarbonyl-1-p-nitrophenylsulfonylazetidin-2-one.
Claim 12
Dependent Claim
13 words
The compound of claim 1 wherein the compound is: cis-4-acetoxy-3-n-propylazetidin-2-one-1-sulfonic acid tetra(n-butyl)ammonium salt.
References Cited (Backward Citations)
US4550105A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-07-13 | 1991-01-12 | 1991-07-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-07-13 | 1995-01-12 | 1995-07-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-07-13 | 1999-01-12 | 1999-07-14 | $7700.00 | Window Closed / Lapsed |